Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Greiner Bio-One

The Preanalytics division develops, manufactures and distributes venous blood collection devices for hospitals, labor... read more Featured Products: More products

Download Mobile App





Greiner Bio-One Exhibits Its New Generation of Sapphire Pipette Tips at MEDICA 2021

By LabMedica International staff writers
Posted on 16 Nov 2021

Greiner Bio-One (Monroe, NC, USA) exhibited its new generation of Sapphire pipette tips at MEDICA 2021, the leading international trade fair for the medical sector. More...

More than 5,000 exhibitors from 70 countries presented their newest products and ideas at this year’s MEDICA which drew 120,000 trade visitors from over 170 countries.

At MEDICA 2021, Greiner presented its new generation of Sapphire pipette tips which are perfect flexibility for laboratory liquid handling and were launched in September. The tips are made of medical polypropylene and benefit from a universal fit on most standard pipettes. They are available in standard, filter, low-retention and filter low-retention versions. By minimizing the adhesion of sample material on the inside of the tip, the low-retention surface ensures maximum precision, even with detergents and other viscous or complex samples. The filter tips reliably prevent the transfer of biological material and aerosols, without this negatively affecting the accuracy of the volume being pipetted. No additives are used when manufacturing the filters. Even after accidental contact, it is therefore possible to continue using samples. In conjunction with Sapphire pipettes, the universal tips offer a fully optimized and harmonized liquid handling solution from a single source. The new pipette tips are produced and packaged at the company’s Austrian plant in Kremsmünster, in a fully automated process that minimizes any potential risk of contamination.

Greiner also showcased its new VACUETTE Virus Stabilization Tube that supports the safe transport and storage of specimens, including COVID-19 swab samples. The company demonstrated how its VACUETTE Virus Stabilization Tube can help alleviate some of the barriers to testing for SARS-CoV-2 that laboratories are experiencing. VACUETTE Virus Stabilization Tubes are intended for the transport and storage of nasopharyngeal and oropharyngeal swab specimens. Meant for use by healthcare professionals for SARS-CoV-2 testing only, VACUETTE Virus Stabilization Tubes are made of PET with a pre-defined volume of a phosphate buffer saline solution at a pH of 7.4±0.2 to allow for the storage of the SARS-CoV-2 swab specimens for up to 72h at 4°C. The tubes are fitted with VACUETTE Safety Caps and the tube interior is sterile. The product is single use only and can be used on a single patient only. The CE-marked VACUETTE Virus Stabilization Tubes are manufactured according to Greiner’s hygienic standards.

Related Links:
Greiner Bio-One


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.